Verified Job
Work from home
Strategy & Ops Manager (Expansion)
Work from home
#48811
Remote / WFH
Careers at Eucalyptus
Job Description
About Eucalyptus
We're on a mission to make good health last a lifetime. More than 1 billion people live with obesity worldwide, driving preventable chronic conditions. We're here to build better long-term care.
Eucalyptus is now part of Hims & Hers, the global leader in personalised health and wellness.
Euc is the company behind Juniper, one of the world's largest weight-management programs combining GLP-1 medication with personalised nutrition, movement support, and clinician-led care from prescribers, nurses, health coaches, pharmacists, and dietitians. Our published clinical research shows that our combined clinical and behavioural approach helps patients lose significantly more weight during their treatment with Juniper by four times.
Our Growth Story:
130% YoY revenue growth and a 90% reduction in cash burn - culminating in our $1.15bn acquisition by Hims & Hers in 2026, giving us the platform to take long-term care global
Supported over 350k patients living with obesity across our 5 markets
Received selective NICE endorsement to provide services to the NHS
Tailored our offering to thousands of patients in Australia, the UK, Germany, Japan and Canada.
Why this role exists
International expansion has been the growth engine behind many of the defining consumer technology companies of our time - Uber, Airbnb, Doordash, Revolut. Our ambition is to be the next version of this in digital health: the world's leading international consumer health platform.
Following our acquisition by Hims & Hers, international expansion is the top priority for Eucalyptus. We're building the international arm of the leading consumer health platform globally and we're growing the team responsible for making that happen.
Our international expansion team owns everything from evaluating whether we should enter a market, to launching and scaling within it. We move fast, operate with high autonomy, and hold ourselves accountable to outcomes.
We see our international expansion work in three phases:
Select new markets: Evaluate new markets, build the business case, make the go/no-go call
Launch new markets: Own a market from post-due-diligence to first patient
iii. Scale launched markets: Win in launched markets by placing data-driven bets and owning the P&L
Depending on where you join and where the business needs you, you'll own one of these phases. As we grow, you will move across all three.
What You'll Be Doing (why this role is interesting)
If you're working on selecting new markets: You are the person we drop into a country and trust to come back with an answer. That means owning the full due diligence process: competitive landscape, regulatory environment, commercial sizing, pharmacy infrastructure, and pharma partnership opportunities. You'll meet with the people who know the market: potential pharmacy partners, pharma companies, advisors, industry experts and you'll synthesise everything into an investment thesis that gives leadership what they need to go/no-go decision.
We're on a mission to make good health last a lifetime. More than 1 billion people live with obesity worldwide, driving preventable chronic conditions. We're here to build better long-term care.
Eucalyptus is now part of Hims & Hers, the global leader in personalised health and wellness.
Euc is the company behind Juniper, one of the world's largest weight-management programs combining GLP-1 medication with personalised nutrition, movement support, and clinician-led care from prescribers, nurses, health coaches, pharmacists, and dietitians. Our published clinical research shows that our combined clinical and behavioural approach helps patients lose significantly more weight during their treatment with Juniper by four times.
Our Growth Story:
130% YoY revenue growth and a 90% reduction in cash burn - culminating in our $1.15bn acquisition by Hims & Hers in 2026, giving us the platform to take long-term care global
Supported over 350k patients living with obesity across our 5 markets
Received selective NICE endorsement to provide services to the NHS
Tailored our offering to thousands of patients in Australia, the UK, Germany, Japan and Canada.
Why this role exists
International expansion has been the growth engine behind many of the defining consumer technology companies of our time - Uber, Airbnb, Doordash, Revolut. Our ambition is to be the next version of this in digital health: the world's leading international consumer health platform.
Following our acquisition by Hims & Hers, international expansion is the top priority for Eucalyptus. We're building the international arm of the leading consumer health platform globally and we're growing the team responsible for making that happen.
Our international expansion team owns everything from evaluating whether we should enter a market, to launching and scaling within it. We move fast, operate with high autonomy, and hold ourselves accountable to outcomes.
We see our international expansion work in three phases:
Select new markets: Evaluate new markets, build the business case, make the go/no-go call
Launch new markets: Own a market from post-due-diligence to first patient
iii. Scale launched markets: Win in launched markets by placing data-driven bets and owning the P&L
Depending on where you join and where the business needs you, you'll own one of these phases. As we grow, you will move across all three.
What You'll Be Doing (why this role is interesting)
If you're working on selecting new markets: You are the person we drop into a country and trust to come back with an answer. That means owning the full due diligence process: competitive landscape, regulatory environment, commercial sizing, pharmacy infrastructure, and pharma partnership opportunities. You'll meet with the people who know the market: potential pharmacy partners, pharma companies, advisors, industry experts and you'll synthesise everything into an investment thesis that gives leadership what they need to go/no-go decision.
